טוען...
BCMA-targeted CAR T-cell therapy plus radiation therapy for the treatment of refractory myeloma reveals potential synergy
We present a case of a patient with multiply-relapsed, refractory myeloma whose clinical course showed evidence of a synergistic abscopal-like response to CAR T-cell therapy and localized radiation therapy (XRT). Shortly after receiving B-cell maturation antigen (BCMA)–targeted CAR T-cell therapy, t...
שמור ב:
| הוצא לאור ב: | Cancer Immunol Res |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6606365/ https://ncbi.nlm.nih.gov/pubmed/31113804 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2326-6066.CIR-18-0551 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|